Release and Expiration Dates
Release Date: 4/6/2020
Expiration Date: 11/29/2025
Last Reviewed Date
11/29/2022
Blood Products and Utilization of Blood for Massive Hemorrhage
Program Overview
Blood Products and Utilization of Blood for Massive Hemorrhage is a course offered in Series 3 of Trauma University, presented at TCAA's 2019 Annual Conference. Course topics are contributed by TCAA members and are designed to provide practitioners with clinical education opportunities. The purpose of this activity is to guidance on blood products and transfusion practices.
Estimated completion time: 60 minutes
Target Audience: The Trauma healthcare team and other clinical departments
Learning Objectives
At the conclusion of this course, the learner should be better able to:
1. Discuss clinical applications of blood components for massive transfusion
2. Restate when it is okay to use O pos vs. O neg RBC for emergency transfusion
3. Identify new trends in blood transfusion practices for massive hemorrhage
Faculty Presenter: Dr. Marissa Li
Presenter Bio
Dr. Marissa Li is the Southwest and West Division Medical Director for Vitalant and Assistant Medical Director for LifeStream Blood Center. She completed her bachelors of sciences degree in neuroscience at UCLA in 2001. Continuing her studies at UCLA she completed her MD degree in 2005. Following one year of internal medicine internship at Kaiser Permanente Hospital, Los Angeles she then completed a pathology residency at Cedars Sinai Medical Center in Los Angeles. Dr. Li subsequently obtained two years of transfusion medicine training both at Cedars Sinai Medical Center and UCLA Medical Center. Her responsibilities include providing clinical consultation to hospitals serviced by Vitalant and LifeStream. Her interests in clinical transfusion medicine include immunohematology, platelet refractoriness, therapeutic apheresis and patient blood management. On the blood center side, Dr. Li is an integral member of the operations and manufacturing departments. Additionally, she has an active role in providing medical guidance on corporate policies and oversight to Vitalant blood centers for both donor and patient related issues.
References
Yazer MH, Cap AP, Spinella PC, Alarcon L, Triulzi DJ. How do I implement a whole blood program for massively bleeding patients? Transfusion. 2018 Mar;58(3):622-628. doi: 10.1111/trf.14474. Epub 2018 Jan 14.
Bjerkvig CK1, Fosse TK, Apelseth TO, Sivertsen J, Braathen H, Eliassen HS, Guttormsen AB, Cap AP, Strandenes G. Emergency sternal intraosseous access for warm fresh whole blood transfusion in damage control resuscitation. J Trauma Acute Care Surg. 2018 Jun;84(6S Suppl 1):S120-S124. doi: 10.1097/TA.0000000000001850.
Gurney JM1,2, Spinella PC2,3. Blood transfusion management in the severely bleeding military patient. Curr Opin Anaesthesiol. 2018 Apr;31(2):207-214. doi: 10.1097/ACO.0000000000000574.
Sivertsen J1, Braathen H, Lunde THF, Spinella PC, Dorlac W, Strandenes G, Apelseth TO, Hervig TA, Kristoffersen EK. Preparation of leukoreduced whole blood for transfusion in austere environments; effects of forced filtration, storage agitation, and high temperatures on hemostatic function. J Trauma Acute Care Surg. 2018 Jun;84(6S Suppl 1):S93-S103. doi: 10.1097/TA.0000000000001896.
Warner N, Zheng J, Nix G, Fisher AD, Johnson JC, Williams JE, Northern DM, Hellums JS. Military Prehospital Use of Low Titer Group O Whole Blood. J Spec Oper Med. 2018 Spring;18(1):15-18.
Nepstad I, Reikvam H, Strandenes G, Hess JR, Apelseth TO, Hervig TA. Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation. Blood Transfus. 2014 Jan;12(1):50-5. doi: 10.2450/2013.0303-12. Epub 2013 Oct 24.
Planners
Timothy Murphy
Dr. Christoph Kaufman
Jennifer Ward
Deb Myers
Dr. Britt Christmas
Peer Reviewer
Dr. Glen Tinkoff